Skip to content
jonsson

Seminar Title

 

Seminar N4: What is an innovative drug?

Affiliation

Medical Products Agency

Country

Sweden

1. Current Status, Position

  • Senior Expert, clinical assessor, Medical Products Agency, Sweden
  • Chair Oncology Working Party, European Medicines Agency
  • Vice Chair Scientific Advice Working Party, European Medicines Agency

2. Education

MD, PhD

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.